Chapter 2 Summary and Highlights
- Market Outlook
- Highlights of the Market for Advanced Drug Delivery Systems
Chapter 3 Market Overview
- Overview
- Evolution of Advanced Drug Delivery Systems
Chapter 4 Market Dynamics
- Overview
- Market Drivers
- Market Restraints
- Market Opportunities
- Impact of COVID-19 on the ADDS Market
Chapter 5 Evaluation of the Market Based on Technology
- Overview of Advanced Drug Delivery Systems and Technologies
- Market Share and Forecast
- Immediate-Release Drug Delivery
- Extended-Release Drug Delivery
- Targeted-Release Drug Delivery
- Delayed-Release Drug Delivery
- Pulsatile-Release Drug Delivery
Chapter 6 Evaluation of the Market Based on Route of Administration
- Overview of Routes of Administration of Drugs
- Market Share and Forecast
- Oral
- Parenteral/Injectable
- Transmucosal
- Transmucosal Nasal and Pulmonary
- Transmucosal Ocular
- Transmucosal Rectal
- Transmucosal Oral Buccal
- Transmucosal Vaginal
- Implant
- Transdermal
- Topical
Chapter 7 Evaluation of the Market Based on Vehicle/Carrier
- Overview of Vehicles/Carriers Used in Advanced Drug Delivery Systems
- Market Share and Forecast
- Nanoparticles
- Monoclonal Antibodies
- Liposomes
- Polymeric Therapeutics
- Dendrimers
- Polymeric Drug
- Polymeric Micelles
- Prodrugs
- Microparticles
- Others
Chapter 8 Evaluation of the Market Based on Application
- Overview of Applications Used in Advanced Drug Delivery Systems
- Market Share and Forecast
- Oncology
- Inflammatory Diseases and Allergies
- Cardiovascular
- Ophthalmic
- Central Nervous System
- Hormone Replacement Therapy and Gynecology
- Viral and Bacterial Diseases
- Diabetes
- Urology
- Gastrointestinal (GI) Disorders
- Dermatology
- Respiratory
- Other Therapeutic
Chapter 9 Evaluation of the Market Based on Geographic Region
- Global Market for ADDS by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
Chapter 10 ESG Development
- Introduction to ESG
- Sustainability in the Advanced Drug Delivery Systems (ADDS) Industry: An ESG Perspective
- Key ESG Issues
- ESG Risk Rankings
- Consumer Attitudes toward ESG in the ADDS Market
- Case Study
- Concluding Remarks
Chapter 11 Emerging Technologies in the Market
- Emerging Technology, ADDS Market
- 3D Printing Technology in Drug Delivery
- Biologics Drug Delivery
- AI in Drug Delivery
- Smart Drug Delivery System
Chapter 12 Clinical Trials and Patent Analysis
- Clinical Trials Analysis
- Clinical Trials Analysis by Type of Study
- Clinical Trials Analysis by Status
- Clinical Trials Analysis by Phase
- Clinical Trials Analysis by Region
- Patent Analysis
- Patents by Year
- Patents by Top Applicant
- Patents by Top Owner
- Patents by Jurisdiction
Chapter 13 Competitive Intelligence
- Market Share Analysis
- Recent Developments of Key Market Players
Chapter 14 Company Profiles
- ABBOTT
- ABBVIE INC.
- ASTRAZENECA
- BD
- BOSTON SCIENTIFIC CORP.
- F. HOFFMANN-LA ROCHE LTD
- JOHNSON & JOHNSON SERVICES INC.
- KINDEVA DRUG DELIVERY
- MEDTRONIC
- MERCK & CO. INC.
- NOVARTIS AG
- PFIZER INC.
- SANOFI S.A.
- TERUMO CORP.
- TEVA PHARMACEUTICAL INDUSTRIES LTD.
List of Tables
Summary Table A: Global Market for Advanced Drug Delivery Systems, by Technology, Through 2028
Summary Table B: Global Market for Advanced Drug Delivery Systems, by Region, Through 2028
Table 1: Global Market for Advanced Drug Delivery Systems, by Technology, Through 2028
Table 2: Main Orally Disintegrating Drug Delivery Technologies
Table 3: Comparison of Different Orally Disintegrating Drug Delivery Technologies
Table 4: Drugs Qualified for Fast-Dissolving Tablet
Table 5: Examples of Drugs Using Orally Disintegrating Drug Delivery Technologies
Table 6: List of Commercially Available Fast Dissolving Tablets (FDTs)
Table 7: List of Commercially Available Fast Dissolving Oral Films
Table 8: Difference Between Sustained vs. Controlled Drug Delivery
Table 9: Classic Methods of Extended-Release Delivery Systems and Their Limitations
Table 10: Examples of Companies Developing Extended Drug Delivery Systems
Table 11: Global Market for Extended-Release Drug Delivery Systems, by Type, Through 2028
Table 12: Examples of Delivery Carriers for Targeted Drug Delivery Systems
Table 13: Examples of FDA-Approved ADC Drugs
Table 14: Examples of Current U.S. FDA-Approved Nanoparticles and Type of Targeting Employed, Indications, Advantages and Drawbacks
Table 15: Examples of Companies Developing Targeted Drug Delivery Systems
Table 16: Examples of Diseases that Require Pulsatile Drug Delivery Systems
Table 17: Examples of FDA-Approved Advanced Pulsatile Drug Delivery Systems
Table 18: Examples of Pulsatile Drug Delivery Systems on the Market and the Market Players That Developed Them
Table 19: Advantages and Disadvantages of Different Routes of Drug Administration
Table 20: Global Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2028
Table 21: Some Oral Advanced Drug Delivery Systems
Table 22: Examples of Specialized Parenteral Routes of Administration
Table 23: Transmucosal Drug Delivery
Table 24: Global Market for Advanced Transmucosal Drug Delivery Systems, by Type, Through 2028
Table 25: Global Market for Advanced Transmucosal Nasal and Pulmonary Drug Delivery Systems, Through 2028
Table 26: Examples of Hydrogels and Composites Developed for Ocular Drug Delivery
Table 27: Global Market for Advanced Ocular Advanced Drug Delivery Systems, Through 2028
Table 28: Examples of Rectal Formulations Clinically Approved
Table 29: Global Market for Advanced Rectal Advanced Drug Delivery Systems, Through 2028
Table 30: Examples of Marketed Medications Delivered, by the Oral-Buccal Route of Administration
Table 31: Global Market for Advanced Oral Buccal Drug Delivery Systems, Through 2028
Table 32: Global Market for Advanced Vaginal Drug Delivery Systems, Through 2028
Table 33: Examples of Implantable Drug Devices on the Market
Table 34: FDA-Approved Transdermal Patches
Table 35: Types of Topical Medications
Table 36: Examples of Advanced Topical Drug Delivery Systems In Clinical Use
Table 37: Global Market for Advanced Drug Delivery Systems, by Drug Delivery Vehicle/Carrier, Through 2028
Table 38: Examples of Nanocarriers in Drug Delivery and Their Characteristics
Table 39: Examples of FDA-Approved Nanodrugs Available for Clinical Use
Table 40: Examples of Clinically Approved Liposome-Based Therapeutics on the Market
Table 41: Some Liposomal Products Approved, by FDA and EMA
Table 42: Global Market for Polymeric Therapeutics for Advanced Drug Delivery Devices, Through 2028
Table 43: Examples of Dendrimer-Drug Interactions in Cancer Therapy
Table 44: Examples of Polymer Drugs Commercially Available
Table 45: Global Market Shares of Advanced Drug Delivery Systems, by Type of Polymeric Drug, 2022
Table 46: Examples of Stimuli-Responsive Polymeric Micelles for Cancer Therapy
Table 47: Examples of FDA-Approved Prodrugs on the Market
Table 48: Comparison of Control Release Devices
Table 49: Ten Leading Causes of Death Globally, 2021
Table 50: Global Market for Advanced Drug Delivery Systems, by Application, Through 2028
Table 51: Worldwide Cancer Incidence, by Type, 2020
Table 52: Examples of Different Systems Used in the Cardiovascular Delivery of Therapeutics
Table 53: Examples of Ophthalmology Drug Delivery Systems
Table 54: Examples of Marketed Nanopharmaceuticals for Brain Disorders
Table 55: Examples of Nanoplatforms for Drug Delivery Approved, by the FDA, EMA and Other Organizations
Table 56: Examples of Antibacterial Drug Delivery Systems
Table 57: Key Facts and Latest Data for Diabetes Globally, 2021 and 2045
Table 58: Commercially Available Insulin Injector Pens & Manufacturers
Table 59: Examples of Drug Delivery Systems for Diabetes Treatment
Table 60: Prevalence of End Stage Renal Disease, by Country, 2020
Table 61: Examples of Gastro-Retentive Products Available in the Market
Table 62: Global Market for Advanced Drug Delivery Systems, by Region, Through 2028
Table 63: Cancer Incidence in Europe, by Select Countries, 2022
Table 64: ESG: Environmental Overview
Table 65: ESG: Social Overview
Table 66: ESG: Governance Overview
Table 67: ESG Rankings for Major ADDS Companies, 2023*
Table 68: Research Projects Using 3D Printing Techniques to Design Drug Delivery Systems
Table 69: List of Smart Drug Delivery Systems
Table 70: Clinical Trials in Drug Delivery System, by Type of Study, as of November 2023
Table 71: Clinical Trials in Drug Delivery System, by Status, as of November 2023
Table 72: Clinical Trials in Drug Delivery System, by Phase, as of November 2023
Table 73: Clinical Trials in Drug Delivery System, by Region, November 2023
Table 74: Patents Granted for Drug Delivery Systems, by Top Applicant, 2018-2022
Table 75: Patents Granted for Drug Delivery Systems, by Top Owner, 2018-2022
Table 76: Patents Granted for Drug Delivery Systems, by Jurisdiction, 2018-2022
Table 77: Advanced Drug Delivery Systems: Market Player Ranking
Table 78: Recent Developments in Global Market for Advanced Drug Delivery Systems, 2020-2023
Table 79: Abbott: Company Snapshot
Table 80: Abbott: Financials, 2021 and 2022
Table 81: Abbott: Product Portfolio
Table 82: Abbott: Key Developments, 2021
Table 83: AbbVie Inc.: Company Snapshot
Table 84: AbbVie Inc.: Financials, 2021 and 2022
Table 85: AbbVie Inc.: Key Developments, 2020
Table 86: AstraZeneca: Company Snapshot
Table 87: BD: Company Snapshot
Table 88: BD: Financials, 2021 and 2022
Table 89: BD: Product Portfolio
Table 90: BD: Key Developments, 2021-2023
Table 91: Boston Scientific Corp.: Company Snapshot
Table 92: Boston Scientific Corp.: Financials, 2021 and 2022
Table 93: Boston Scientific Corp.: Product Portfolio
Table 94: Boston Scientific Corp.: Key Developments, 2022
Table 95: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 96: F. Hoffmann-La Roche Ltd.: Financials, 2021 and 2022
Table 97: Johnson & Johnson Services Inc.: Company Snapshot
Table 98: Johnson & Johnson Services Inc.: Financials, 2021 and 2022
Table 99: Johnson & Johnson Services Inc.: Key Developments, 2022
Table 100: Kindeva Drug Delivery: Company Snapshot
Table 101: Medtronic plc: Company Snapshot
Table 102: Medtronic plc: Financials, 2021 and 2022
Table 103: Medtronic plc: Product Portfolio
Table 104: Medtronic plc: Key Developments, 2023
Table 105: Merck & Co. Inc.: Company Snapshot
Table 106: Merck & Co. Inc.: Financials, 2021 and 2022
Table 107: Novartis AG: Company Snapshot
Table 108: Novartis AG: Financials, 2021 and 2022
Table 109: Novartis AG: Key Developments, 2020-2022
Table 110: Pfizer Inc.: Company Snapshot
Table 111: Pfizer Inc.: Financials, 2021 and 2022
Table 112: Sanofi S.A.: Company Snapshot
Table 113: Sanofi S.A.: Financials, 2021 and 2022
Table 114: Terumo Corp.: Company Snapshot
Table 115: Terumo Corp.: Product Portfolio
Table 116: Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 117: Teva Pharmaceutical Industries Ltd.: Financials, 2021 and 2022
Table 118: Acronyms Used in This Report
List of Figures
Summary Figure A: Global Market for Advanced Drug Delivery Systems, by Technology, 2020-2028
Summary Figure B: Global Market for Advanced Drug Delivery Systems, by Region, 2020-2028
Figure 1: Conventional vs. Advanced Drug Delivery
Figure 2: Conventional vs. Advanced Dosage Forms
Figure 3: Evolution of Advanced Drug Delivery System, Since 1950s
Figure 4: Global Markets and Technologies for Advanced Drug Delivery Systems Market Dynamics
Figure 5: Categories of Therapeutic and Delivery Approaches
Figure 6: Global Market for Advanced Drug Delivery Systems, by Technology
Figure 7: Global Market Shares of Advanced Drug Delivery Systems, by Technology, 2022
Figure 8: Global Market for Immediate Drug Release Technology, 2020-2028
Figure 9: Extended Drug Delivery, by Type
Figure 10: Global Market for Extended-Release Drug Delivery Systems, 2020-2028
Figure 11: Global Market for Extended-Release Drug Delivery Systems, by Type, 2020-2028
Figure 12: Global Market for Targeted-Release Drug Delivery Systems, 2020-2028
Figure 13: Global Market for Delayed-Release Drug Delivery Systems, 2020-2028
Figure 14: Global Market for Pulsatile Release Drug Delivery Systems, 2020-2028
Figure 15: Global Market Shares of Advanced Drug Delivery Systems, by Route of Administration, 2022
Figure 16: Oral Drug Delivery: Market Overview
Figure 17: Global Market for Oral Advanced Drug Delivery Systems, 2020-2028
Figure 18: Global Market for Parenteral/Injectable Advanced Drug Delivery Systems, 2020-2028
Figure 19: Global Market for Advanced Transmucosal Drug Delivery Systems, 2020-2028
Figure 20: Global Market for Advanced Transmucosal Drug Delivery Systems, by Type, 2020-2028
Figure 21: Global Market for Advanced Implant Drug Delivery Systems, 2020-2028
Figure 22: Global Market for Advanced Transdermal Drug Delivery Systems, 2020-2028
Figure 23: Global Market for Advanced Topical Drug Delivery Systems, 2020-2028
Figure 24: Global Market Shares of Advanced Drug Delivery Systems, by Drug Delivery Vehicle/Carrier, 2022
Figure 25: Global Market for Nanoparticles for Advanced Drug Delivery Systems, 2020-2028
Figure 26: Global Market for Monoclonal Antibodies for Advanced Drug Delivery Devices, 2020-2028
Figure 27: Global Market for Liposomes for Advanced Drug Delivery Systems, 2020-2028
Figure 28: Global Market for Polymeric Therapeutics for Advanced Drug Delivery Systems, 2020-2028
Figure 29: Global Market for Polymeric Therapeutics for Advanced Drug Delivery Devices, 2020-2028
Figure 30: Global Market Shares of Advanced Drug Delivery Systems, by Type of Polymeric Drugs, 2022
Figure 31: Global Market for Prodrugs for Advanced Drug Delivery Devices, 2020-2028
Figure 32: Global Market for Microparticles/Microspheres for Advanced Drug Delivery Devices, 2020-2028
Figure 33: Global Market for Other Drug Delivery Vehicles/Carriers for Advanced Drug Delivery Systems, 2020-2028
Figure 34: Global Market Shares of Advanced Drug Delivery Systems, by Application, 2022
Figure 35: Global Market for Advanced Drug Delivery Systems in Oncology Applications, 2020-2028
Figure 36: Global Market for Advanced Drug Delivery Systems in Inflammatory and Allergy Applications, 2020-2028
Figure 37: Global Market for Advanced Drug Delivery Systems in Cardiovascular Applications, 2020-2028
Figure 38: Global Market for Advanced Drug Delivery Systems in Ophthalmic Applications, 2020-2028
Figure 39: Global Market for Advanced Drug Delivery Systems in Central Nervous System Applications, 2020-2028
Figure 40: Global Market for Advanced Drug Delivery Systems in Hormone Replacement Therapy and Gynecological Applications, 2020-2028
Figure 41: Influenza Burden Estimates in the U.S., October 2022 to April 2023
Figure 42: Global Market for Advanced Drug Delivery Systems in Viral and Bacterial Diseases Applications, 2020-2028
Figure 43: Global Market for Advanced Drug Delivery Systems in Diabetes Applications, 2020-2028
Figure 44: Global Market for Advanced Drug Delivery Systems in Urology Applications, 2020-2028
Figure 45: Global Market for Advanced Drug Delivery Systems in Gastrointestinal Disorder Applications, 2020-2028
Figure 46: Global Market for Advanced Drug Delivery Systems in Dermatology Applications, 2020-2028
Figure 47: Global Market for Advanced Drug Delivery Systems in Respiratory Applications, 2020-2028
Figure 48: Global Market for Advanced Drug Delivery Systems in Other Therapeutic Applications, 2020-2028
Figure 49: Global Market Shares of Advanced Drug Delivery Systems, by Region, 2022
Figure 50: North American Market for Advanced Drug Delivery Systems, 2020-2028
Figure 51: European Market for Advanced Drug Delivery Systems, 2020-2028
Figure 52: Asia-Pacific Market for Advanced Drug Delivery Systems, 2020-2028
Figure 53: Rest of the World Market for Advanced Drug Delivery Systems, 2020-2028
Figure 54: ESG Pillars
Figure 55: Advantages of ESG for Biopharmaceutical Companies
Figure 56: ESG-Adoption Level Across All the Industries, Global, 2021 and 2022
Figure 57: Hospitals: Sustainability Priorities
Figure 58: Novartis: Major ESG Activities, 2022
Figure 59: Patents Granted for Drug Delivery Systems, by Year, 2018-2022
Figure 60: Major Pharmaceutical Players in the ADDS Market
Figure 61: Major Medical Device Players in the ADDS Market
Figure 62: Major CDMO Players in the ADDS Market
Figure 63: Major CDMO Players in the ADDS Market
Figure 64: Abbott: Revenue Share, by Business Unit, 2022
Figure 65: Abbott: Revenue Share, by Region, 2022
Figure 66: AbbVie Inc.: Financials, 2021 and 2022
Figure 67: AbbVie Inc.: Revenue Share, by Business Unit, 2022
Figure 68: AbbVie Inc.: Revenue Share, by Region, 2022
Figure 69: BD: Financials, 2021 and 2022
Figure 70: BD: Revenue Share, by Business Unit, 2022
Figure 71: BD: Revenue Share, by Region, 2022
Figure 72: Boston Scientific Corp.: Financials, 2021 and 2022
Figure 73: Boston Scientific Corp.: Revenue Share, by Business Unit, 2022
Figure 74: Boston Scientific Corp.: Revenue Share, by Country/Region, 2022
Figure 75: F. Hoffmann-La Roche Ltd.: Financials, 2021 and 2022
Figure 76: F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, 2022
Figure 77: F. Hoffmann-La Roche Ltd.: Revenue Share, by Region, 2022
Figure 78: Johnson & Johnson Services Inc.: Financials, 2021 and 2022
Figure 79: Johnson & Johnson Services Inc.: Revenue Share, by Business Segment, 2022
Figure 80: Johnson & Johnson Services Inc.: Revenue Share, by Country/Region, 2022
Figure 81: Medtronic plc: Financials, 2021 and 2022
Figure 82: Medtronic plc: Market Share, by Business Unit, 2022
Figure 83: Medtronic plc: Market Share, by Region, 2022
Figure 84: Merck & Co. Inc.: Financials, 2021 and 2022
Figure 85: Merck & Co. Inc.: Revenue Share, by Business Unit, 2022
Figure 86: Merck & Co. Inc.: Revenue Share, by Country/Region, 2022
Figure 87: Novartis AG: Financials, 2021 and 2022
Figure 88: Novartis AG: Revenue Share, by Business Unit, 2022
Figure 89: Novartis AG: Revenue Share, by Region, 2022
Figure 90: Pfizer Inc.: Financials, 2021 and 2022
Figure 91: Pfizer Inc.: Revenue Share, by Business Unit, 2022
Figure 92: Pfizer Inc.: Revenue Share, by Region, 2022
Figure 93: Sanofi S.A.: Financials, 2021 and 2022
Figure 94: Sanofi S.A.: Revenue Share, by Business Unit, 2022
Figure 95: Sanofi S.A.: Revenue Share, by Region, 2022 (%)
Figure 96: Teva Pharmaceutical Industries Ltd.: Financials, 2021 and 2022
Figure 97: Teva Pharmaceutical Industries Ltd.: Revenue Share, by Business Unit, 2022
Figure 98: Teva Pharmaceutical Industries Ltd.: Revenue Share, by Region, 2022
